Muhammad Khalid, MD
Allergy & Immunology · Newark, DENPI 1760902936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,618 of the $2,958 with a category attached, or 88.5%. It is spread thinly across 19 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,581, more than ten times the $28 reported in 2020.
Across 141 payments — averaging $20.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$654
- Regeneron Healthcare Solutions, Inc.$612
- GSK$492
- Takeda Pharmaceuticals U.S.A., Inc.$277
- CSL Behring$194
- Amgen$110
- plus $620 from 13 others
What the payments were for
- Food & beverage$2,61888%
- Education$34012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $654 |
| Regeneron Healthcare Solutions, Inc. | 25 | $612 |
| GSK | 27 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $277 |
| CSL Behring | 7 | $194 |
| Amgen | 6 | $110 |
| Novartis | 6 | $109 |
| Genentech USA, Inc. | 3 | $79 |
| Greer Laboratories, Inc. | 3 | $65 |
| Sanofi | 2 | $61 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $54 |
| Grifols USA, LLC | 3 | $52 |
| Optinose US, Inc. | 3 | $47 |
| Pfizer | 2 | $41 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
How this compares
Too few allergy & immunology providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 13 | $8,398 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 32 | $8,189 |
| Arnuity ElliptaFluticasone Furoate | 14 | $5,964 |
| Wixela InhubFluticasone Propion/Salmeterol | 19 | $3,359 |
| Epinephrine | 16 | $3,211 |
| Azelastine Hcl | 94 | $3,154 |
| Ipratropium Bromide | 88 | $2,524 |
| Fluticasone Propionate | 65 | $1,394 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $964 |
| Montelukast Sodium | 23 | $432 |
| Famotidine | 28 | $371 |
| Triamcinolone Acetonide | 16 | $105 |
| Mupirocin | 14 | $103 |
| Azithromycin | 15 | $74 |
| Prednisone | 46 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta | $492 | $14,36327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Delawareon file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Newark
- Junfang JiaoNewark$20K
- Sokun BhattiNewark$5K
- David WienWilmington$17K
- Gregory MarcotteWilmington$17K
- Michael WydilaWilmington$7K
- Michelle SquadritoWilmington$5K
- Lyvia LeighLewes$4K
- Richard KimWilmington$4K
- Isma ShahWilmington$3K
- Amulya AmirneniLewes$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.